ACTIVE

Advanz Pharma Belgium

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result27,6 k €+103,1 %over 1 year

Gross margin288,4 k €-35,1 %over 1 year

Equity181 k €+18,0 %over 1 year

Workforce1,5 ETP-25,0 %over 1 year

Identity

Source · BCE/KBO

Advanz Pharma Belgium is a Private limited company incorporated in 2011. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Saint-Josse-ten-Noode. It employs on average 1,5 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0833.413.211
Incorporation: 03/02/2011
Legal form: Private limited company
Registered office: Boulevard Saint-Lazare 4-10
1210 Saint-Josse-ten-Noode · BruxellesSee on map
Contributed capital: 12 000,00 €
Latest accounts: 31/12/2025
Average workforce: 1,5 ETP

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods 70200Management consultancy activities 70220Business and other management consultancy activities

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 15 filings

Trend over 14 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	288,4 k €	-35.1%	444,6 k €	+5.9%	419,7 k €	+15.5%	363,4 k €	+81.7%	200 k €
EBITDA	19,4 k €	-37.9%	31,3 k €	-14.7%	36,6 k €	-10.0%	40,7 k €	+129%	17,8 k €
Operating result	19,4 k €	-37.9%	31,3 k €	-14.7%	36,6 k €	-10.0%	40,7 k €	+129%	17,8 k €
Net result	27,6 k €	+103%	13,6 k €	-54.8%	30,1 k €	-2.0%	30,7 k €	+244%	8,9 k €
Balance sheet
Equity	181 k €	+18.0%	153,4 k €	+9.7%	139,8 k €	+27.4%	109,8 k €	+38.8%	79,1 k €
Total assets	365,4 k €	+29.8%	281,4 k €	-5.5%	297,9 k €	+39.3%	213,9 k €	+60.1%	133,6 k €
Cash	300,9 k €	+132%	129,6 k €	-26.5%	176,3 k €		–		–
Debts	179,6 k €	+40.7%	127,7 k €	-16.7%	153,3 k €	+53.1%	100,1 k €	+83.7%	54,5 k €
Other
Workforce	1,5 ETP	-25.0%	2,0 ETP	+100%	1,0 ETP	-50.0%	2,0 ETP	+122%	0,9 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 17 ended

Active mandates

Director	Mandates in this company	Period
Andreas Stickler	Directorsince 31/01/2022
Simon Tuckler	Directorsince 27/05/2020

Ended mandates

Director	Mandates in this company	Period
Adeel Ahmad	Director27/05/2020 → 2021 accounts
Paul Burden	Director27/05/2020 → 2021 accounts

Other companies at this address

Boulevard Saint-Lazare 4-10 1210 Saint-Josse-ten-Noode

Company	CBE no.
ACCIONA ESCO BELGIUM● Active	0803.796.834
Act1 Group-Agile1 Belgium● Active	0505.951.505
ADM PROMOTIONS BELGIUM● Active	0721.470.459
ADNIL● Active	0457.561.866
AdsWizz Belgium● Active	0700.713.746
Agra CEAS CONSULTING-Bureau Européen de Recherches● Active	0418.044.660
AIH Monceau Marquis● Active	0788.984.538
ALLIANCE LAUNDRY● Active	0884.949.212
Altech Group● Active	0784.293.894
AMPLIDATA● Active	0882.574.492
APPLE RETAIL BELGIUM● Active	0836.157.420
ASP BELGIUM● Active	0691.974.442
Association des Copropriétaires des immeubles CV10, CV18 et CV9(pie) à LLN● Liquidation	0850.267.554
Aurorium Belgium● Active	0859.877.878
Aurorium Belgium 2● Active	0414.094.681
Aurorium Holdings Belgium● Active	0480.481.976
Bavarian Nordic Belgium● Active	1009.484.146
BeClimate Hub● Active	1029.642.231
Blueberries Holdings● Active	0759.758.537
BLUE SEA HOLDING● Active	0771.845.232

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	15/07/2026	31/07/2025	25/07/2024	31/07/2023	15/02/2023	21/04/2022
General meeting	29/06/2026	30/07/2025	28/06/2024	27/07/2023	22/12/2022	18/03/2022
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 15 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	29/06/2026	15/07/2026	French	PDF
Abridged model	31/12/2024	30/07/2025	31/07/2025	French	PDF
Abridged model	31/12/2023	28/06/2024	25/07/2024	French	PDF
Abridged model	31/12/2022	27/07/2023	31/07/2023	French	PDF
Abridged model	31/12/2021	22/12/2022	15/02/2023	French	PDF
Abridged model	31/12/2020	18/03/2022	21/04/2022	French	PDF
Abridged model	31/12/2019	15/11/2020	19/03/2021	French	PDF
Abridged model	31/12/2018	05/06/2019	11/06/2019	French	PDF
Abridged model	31/12/2017	06/06/2018	07/06/2018	French	PDF
Full model	31/12/2016	07/06/2017	13/06/2017	French	PDF
Full model	31/12/2015	07/06/2016	28/06/2016	French	PDF
Full model	31/12/2014	28/08/2015	31/08/2015	French	PDF
Full model	31/12/2013	04/06/2014	03/07/2014	French	PDF
Full model	31/12/2012	05/06/2013	13/06/2013	French	PDF
Full model	31/12/2011	31/08/2012	08/11/2012	French	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 17 ended

Active mandates

Director	Mandates in this company	Period
Andreas Stickler	Directorsince 31/01/2022
Simon Tuckler	Directorsince 27/05/2020

Ended mandates

Director	Mandates in this company	Period
Adeel Ahmad	Director27/05/2020 → 2021 accounts
Paul Burden	Director27/05/2020 → 2021 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Registered office10/02/2025
Changement du siège de la Société
PDF
Mandates29/08/2023
Changement représentant du commissaire
PDF
Mandates01/08/2022
Démission d’un administrateur de la Société
PDF
Mandates10/05/2022
Renouvellement du mandat du commissaire
PDF
Registered office28/04/2022
Transfert du siège de la Société
PDF
Mandates04/03/2022
Démission et nomination d'administrateurs
PDF
Mandates23/07/2021
Démission d'administrateur
PDF
Mandates06/04/2021
MODIFICATION FORME JURIDIQUE, DENOMINATION, STATUTS
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings14 filings

Mandates

Andreas Stickler

Simon Tuckler

Adeel Ahmad

Paul Burden

Simon Tucker

Thibaut Santiard

Justin Andrew Renz

Jennifer Archibald

David MC Masters

Andreas Günther Jürgen

Jürgen Andreas Günther

Michael Robert Grau

Show the 7 other mandates

2011201220132014201520162017201820192020202120222023202420252026

Advanz Pharma Belgium

Boulevard Saint-Lazare 4-10, 1210 Saint-Josse-ten-NoodeAvenue du Port 86C bte 204, 1000 Brussels

Director

DirectorManager

Manager

DirectorManager

Manager

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Boulevard Saint-Lazare 4-10, 1210 Saint-Josse-ten-NoodeCurrent	accounts 2024 → 2025	Accounts 2025 · 2026-00314747
Avenue du Port 86C bte 204, 1000 Brussels	accounts 2021 → 2023	Accounts 2023 · 2024-00282901
Avenue Pasteur 6 bte H, 1300 Wavre	accounts 2020	Accounts 2020 · 2022-20005497

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
Advanz Pharma BelgiumCurrent	accounts 2020 → 2025	Accounts 2025 · 2026-00314747

Events

2025
Annual accounts 202527,6 k €↑
2024
Annual accounts 202413,6 k €↓
2023
Annual accounts 202330,1 k €↓
2022
Annual accounts 202230,7 k €↑
2021
Annual accounts 20218,9 k €↑
2020
Annual accounts 2020659,6 €↑
2018
Annual accounts 2018-2,6 k €↑
2017
Annual accounts 2017-5,1 k €↓
2016
Annual accounts 20161,9 k €↓
2015
Annual accounts 2015
2014
Annual accounts 20142,6 k €↓
2013
Annual accounts 201322,4 k €↑
2012
Annual accounts 201218,6 k €↓
2011
Annual accounts 201123,1 k €
03/02/2011
IncorporationPrivate limited company

Advanz Pharma Belgium

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events